The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs by $7.3 billion over six years.
The fatal shooting revealed deep resentment of the health insurance industry and the role the company plays in it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback